TCRT · ISSUER CIK 1107421
Alaunos Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Alaunos Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202616:30 | Oct 6, 2026 | TCRT | CEO | A · Grant | $0.74 | +23,564 | 49,047 | +92% | $18K | ||
| Oct 8, 202616:30 | Oct 6, 2026 | TCRT | Director | A · Grant | $0.74 | +22,669 | 70,311 | +48% | $17K | ||
| Oct 8, 202616:30 | Oct 6, 2026 | TCRT | Director | A · Grant | $0.74 | +21,829 | 80,438 | +37% | $16K | ||
| Oct 8, 202616:30 | Oct 6, 2026 | TCRT | Director | A · Grant | $0.74 | +20,990 | 44,749 | +88% | $16K | ||
| Aug 11, 202616:15 | Aug 6, 2026 | TCRT | CEO | A · GrantLate 5d | $2.01 | +4,363 | 25,483 | +21% | $9K |